FABP4 and coronary atherosclerosis: Previous studies using in vitro and in vivo experiments showed that FABP4 acts as an adipokine for the development of hepatic insulin resistance through increased hepatic glucose production21 and for the development of coronary atherosclerosis via induction of proinflammatory responses in macrophages, vascular smooth muscle cells and vascular endothelial cells23.